BioCentury | Aug 22, 2019
Translation in Brief

Systems biology orders strategy to avoid cross-drug resistance in cancer

...A Harvard and Mitra Biotech team used systems biology to identify a temporal treatment regimen that uses...
...a principal investigator at Brigham and Women's Hospital and director of R&D and immuno-oncology at Mitra Biotech Inc....
...deployed to overcome resistance development." Aaron Goldman, Harvard Medical School, Brigham and Women's Hospital and Mitra Biotech Inc....
BioCentury | Sep 5, 2016
Financial News

Mitra Biotech completes venture financing

Mitra Biotech Inc. , Boston, Mass. Business: Diagnostic, Cancer Date completed: 2016-08-29 Type: Venture financing Raised: $27.4 million Investors: Sequoia Capital; Sands Capital; RA Capital Management; Accel Partners; Tata Capital WIR Staff...
BioCentury | Aug 29, 2016
Financial News

Cancer diagnostic play Mitra raises $27.4M

Mitra Biotech Inc. (Boston, Mass.) raised $27.4 million in a series B round led by Sequoia India and Sands Capital Ventures. Other investors included RA Capital Management and existing investors Accel Partners and Tata Capital...
BioCentury | Apr 2, 2015
Distillery Techniques

Techniques: CANScript platform to predict treatment responses in cancer patients

...predicted patient response to standard therapy with 92% specificity and 100% sensitivity. Next steps by Mitra Biotech Inc....
...decisions. DESCRIPTION: CANScript platform to predict treatment responses in cancer patients LICENSING STATUS: Patented by Mitra Biotech Inc....
...et al. Nat. Commun.; published online Feb. 27, 2015 doi: 10.1038/ncomms7169 CONTACT: Pradip K. Majumder, Mitra Biotech Inc....
Items per page:
1 - 4 of 4
BioCentury | Aug 22, 2019
Translation in Brief

Systems biology orders strategy to avoid cross-drug resistance in cancer

...A Harvard and Mitra Biotech team used systems biology to identify a temporal treatment regimen that uses...
...a principal investigator at Brigham and Women's Hospital and director of R&D and immuno-oncology at Mitra Biotech Inc....
...deployed to overcome resistance development." Aaron Goldman, Harvard Medical School, Brigham and Women's Hospital and Mitra Biotech Inc....
BioCentury | Sep 5, 2016
Financial News

Mitra Biotech completes venture financing

Mitra Biotech Inc. , Boston, Mass. Business: Diagnostic, Cancer Date completed: 2016-08-29 Type: Venture financing Raised: $27.4 million Investors: Sequoia Capital; Sands Capital; RA Capital Management; Accel Partners; Tata Capital WIR Staff...
BioCentury | Aug 29, 2016
Financial News

Cancer diagnostic play Mitra raises $27.4M

Mitra Biotech Inc. (Boston, Mass.) raised $27.4 million in a series B round led by Sequoia India and Sands Capital Ventures. Other investors included RA Capital Management and existing investors Accel Partners and Tata Capital...
BioCentury | Apr 2, 2015
Distillery Techniques

Techniques: CANScript platform to predict treatment responses in cancer patients

...predicted patient response to standard therapy with 92% specificity and 100% sensitivity. Next steps by Mitra Biotech Inc....
...decisions. DESCRIPTION: CANScript platform to predict treatment responses in cancer patients LICENSING STATUS: Patented by Mitra Biotech Inc....
...et al. Nat. Commun.; published online Feb. 27, 2015 doi: 10.1038/ncomms7169 CONTACT: Pradip K. Majumder, Mitra Biotech Inc....
Items per page:
1 - 4 of 4